Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study

PURPOSE: Hypoxia is a major factor in prostate cancer aggressiveness and radioresistance. Predicting which patients might be bad candidates for radiotherapy may help better personalize treatment decisions in intermediate-risk prostate cancer patients. We assessed spatial distribution of (18)F-Misoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Supiot, Stéphane, Rousseau, Caroline, Dore, Mélanie, Cheze-Le-Rest, Catherine, Kandel-Aznar, Christine, Potiron, Vincent, Guerif, Stéphane, Paris, François, Ferrer, Ludovic, Campion, Loïc, Meingan, Philippe, Delpon, Gregory, Hatt, Mathieu, Visvikis, Dimitris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839367/
https://www.ncbi.nlm.nih.gov/pubmed/29515786
http://dx.doi.org/10.18632/oncotarget.24234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839367/
https://www.ncbi.nlm.nih.gov/pubmed/29515786
http://dx.doi.org/10.18632/oncotarget.24234

Ejemplares similares